
Pappas Capital
Description
Pappas Capital is a well-established venture capital firm specializing in the life sciences sector, founded in 1994 and based in Durham, North Carolina. The firm is dedicated to bridging the early-stage funding gap for innovative companies developing new products and technologies in biotechnology, pharmaceuticals, medical devices, and diagnostics. With a long-standing track record, Pappas Capital has successfully raised over $600 million in capital across five venture capital funds, demonstrating significant commitment to the life sciences ecosystem.
Investor Profile
Pappas Capital has backed more than 33 startups, with 3 new investments in the last 12 months alone. The firm has led 3 rounds, about 9% of its total and boasts 9 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series A, Series B, Series Unknown rounds (top funding stages).
- Majority of deals are located in United States, Singapore, Canada.
- Strong thematic focus on Biotechnology, Medical, Health Care.
- Typical check size: $1M – $5M.
Stage Focus
- Series A (42%)
- Series B (18%)
- Series Unknown (15%)
- Series C (12%)
- Series D (6%)
- Post Ipo Equity (6%)
Country Focus
- United States (76%)
- Singapore (12%)
- Canada (6%)
- China (6%)
Industry Focus
- Biotechnology
- Medical
- Health Care
- Pharmaceutical
- Therapeutics
- Software
- Life Science
- Medical Device
- Genetics
- Artificial Intelligence (Ai)
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
Who does Pappas Capital frequently co-invest with?
Which angels does Pappas Capital often collaborate with?
What are some of recent deals done by Pappas Capital?
Find More Investors Like Pappas Capital
Discover similar investors in our database and build your perfect investor list.
Need help with your fundraising strategy?Read our fundraising guides









